BlackRock Investment Management’s Core Laboratories CLB Stock Holding History

BlackRock Investment Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$655K	Buy	5,458 +1,013	+23%	+$112K	﹤0.01%	2935
2016 Q3	$499K	Sell	4,445 -470	-10%	-$54.1K	﹤0.01%	3048
2016 Q2	$609K	Buy	4,915 +68	+1%	+$8.21K	﹤0.01%	2949
2016 Q1	$545K	Hold	4,847	–	–	﹤0.01%	2862
2015 Q4	$527K	Buy	4,847 +2	+0%	+$229	﹤0.01%	2987
2015 Q3	$484K	Sell	4,845 -18	-0.4%	-$1.96K	﹤0.01%	3042
2015 Q2	$555K	Hold	4,863	–	–	﹤0.01%	3087
2015 Q1	$508K	Buy	4,863 +6	+0.1%	+$639	﹤0.01%	2959
2014 Q4	$584K	Sell	4,857 -735	-13%	-$96.5K	﹤0.01%	2924
2014 Q3	$818K	Buy	5,592 +95	+2%	+$14.7K	﹤0.01%	2654
2014 Q2	$918K	Buy	5,497 +429	+8%	+$76.3K	﹤0.01%	2666
2014 Q1	$1.01M	Buy	5,068 +1,298	+34%	+$245K	﹤0.01%	2504
2013 Q4	$720K	Sell	3,770 -26	-0.7%	-$4.84K	﹤0.01%	2739
2013 Q3	$642K	Buy	3,796 +82	+2%	+$12.7K	﹤0.01%	2754
2013 Q2	$563K	Buy	+3,714	New	+$526K	﹤0.01%	2779

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BlackRock Investment Management's CLB Position: Q4 2016 in Review

BlackRock Investment Management increased its Core Laboratories (CLB) stake by 23% in Q4 2016, buying an estimated $112K and bringing the position to 5,458 shares worth $655K. The position accounts for ﹤0.01% of the portfolio, ranked #2935.

BlackRock Investment Management first reported a position in CLB in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.01M in Q1 2014. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

BlackRock Investment Management held 5,458 shares of Core Laboratories worth $655K as of Q4 2016.
BlackRock Investment Management bought 1,013 Core Laboratories shares in Q4 2016, an estimated $112K.
Core Laboratories made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2935 holding.
BlackRock Investment Management first reported a position in Core Laboratories in Q2 2013 and has held it in 15 quarters since.
BlackRock Investment Management's Core Laboratories position peaked at $1.01M in Q1 2014.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.